4//SEC Filing
Scott Randal W. 4
Accession 0001209191-23-057374
CIK 0001743881other
Filed
Dec 4, 7:00 PM ET
Accepted
Dec 5, 4:00 PM ET
Size
7.4 KB
Accession
0001209191-23-057374
Insider Transaction Report
Form 4
Scott Randal W
Director
Transactions
- Sale
Common Stock
2023-12-01$30.00/sh−1,500$45,000→ 11,000 total(indirect: See Footnote) - Sale
Common Stock
2023-12-01$28.50/sh−1,000$28,500→ 12,500 total(indirect: See Footnote)
Holdings
- 5,000
Common Stock
Footnotes (2)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by Thinking Bench Capital LLC on June 6, 2023.
- [F2]By Thinking Bench Capital LLC.
Documents
Issuer
BridgeBio Pharma, Inc.
CIK 0001743881
Entity typeother
Related Parties
1- filerCIK 0001337801
Filing Metadata
- Form type
- 4
- Filed
- Dec 4, 7:00 PM ET
- Accepted
- Dec 5, 4:00 PM ET
- Size
- 7.4 KB